Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    25.00 (0.46%)
Bid:
5,450.00
Ask:
5,550.00
Spread: 100.00 (1.835%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Directorate Change

2 Nov 2021 07:00

RNS Number : 9894Q
Camellia PLC
02 November 2021
Β 

2 November 2021

Camellia Plc

(the "Company")

Β 

Directorate Change

Β 

Camellia Plc is pleased to announce the appointment of Stephen Buckland as a non-executive director of the Company with effect from 1 November 2021.

Β 

Stephen previously held positions within the Camellia Group's agricultural and banking businesses. He is a trustee of two charities: The Sir Percival Griffiths' Tea Planters Trust and The Camellia Foundation, a UK charity whose primary donor is the ultimate majority shareholder of Camellia Plc. Through its subsidiary, The Camellia Foundation in Bermuda controls 51.67 per cent of the voting rights of Camellia Plc.

Β 

Additional Disclosures

Β 

The following information is required pursuant to Schedule 2(g) of the AIM Rules for Companies.

Β 

Mr Stephen Charles Buckland (aged 54), holds, or has held, the following current and former directorships/partnerships in the last five years.

Β 

Current directorships/partnershipsΒ 

Past directorships/ partnerships within the last 5 years

The Camellia Foundation (UK)

None

The Sir Percival Griffiths' Tea Planters Trust

Β 

Β 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

Β 

Enquiries

Β 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Tom Franks, CEO

Β 

Panmure Gordon

Nominated Advisor and Broker 020 7886 2500

Emma Earl

Erik Anderson

Β 

Maitland/AMO

PR

William Clutterbuck 07785 292617

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABBBLTMTBMBIB
Date   Source Headline
3rd Aug 200510:17 amRNSEPT Disclosure
1st Aug 200510:21 amRNSEPT Disclosure
27th Jul 200510:30 amRNSEPT Disclosure
26th Jul 200511:05 amRNSEPT Disclosure
20th Jul 200510:35 amRNSEPT Disclosure
18th Jul 200510:29 amRNSEPT Disclosure
7th Jul 200511:16 amRNSEPT Disclosure
17th Jun 200510:40 amRNSEPT Disclosure
13th Jun 20056:00 pmRNSEPT Disclosure
7th Jun 20051:00 pmRNSAGM Statement
7th Jun 200510:50 amRNSStatement re possible offer
7th Jun 200510:50 amRNSStatement re possible offer
9th May 20052:00 pmRNSReport and accounts 2004
28th Apr 20053:04 pmRNSFinal Results
31st Mar 20054:01 pmRNSEACP
17th Feb 20052:01 pmRNSAcquisition
3rd Feb 200512:17 pmRNSEACP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.